Breast Cancer

The recent phase III OLYMPIAD trial findings show improved progression-free survival from olaparib in patients with BRCA-positive, HER2-negative breast cancer.

A new study found that high breast density surpasses other risk factors for breast cancer.

The clinical benefits and safety profiles for ribociclib remained consistent when treating both younger and elderly patients with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer.

Oral adherence is a growing problem for patients with breast cancer.

Online, self-care, coping skills curriculum "Reimagine" helped relieve depression and fatigue in breast cancer survivors.

Patients in a small study who were placed on a certain diet plan for three months saw a decrease in fatigue from breast cancer treatments.

Sam Smith, PhD, discusses the relationship between menopausal symptoms and non-adherence in patients receiving tamoxifen.

Denise Yardley discusses the tnAcity study for patients with metastatic triple-negative breast cancer (TNBC), and nab-paclitaxel.

For partners of younger patients with breast cancer, coping strategies can affect their anxiety even after treatment.

Krista Qualmann discusses hereditary cancer syndromes.

Tara Sanft discusses how nurses can help support a patient with breast cancer who fears recurrence.

A recent study aimed to determine the when and why chemotherapy-induced cognitive impairment, or chemobrain, occurs, who is most likely to develop it, and whether certain factors (such as age, race, menopausal status, etc) play any role.

Debu Tripathy discuss how to encouragecompliance and adherence for patients with breast cancer who are receiving hormone therapy.

Contrary to popular belief, it is possible to have a healthy pregnancy with a breast cancer diagnosis, as long as treatment is monitored and administered correctly.

The Insight web-based program led to improvements in chemotherapy-induced cognitive symptoms and may be an effective and cost-effective treatment.

Krista Qualmann explains what a meeting with a genetic counselor will look like for a patient.

Longer intervals between zoledronic acid doses for patients with bone metastases did not result in an increased risk of skeletal-related events (SREs).

A recent study found that young women with breast cancer who are BRCA-positive have similar, or better, outcomes than those who do not, and that preventative bilateral mastectomy in this population does not improve the risk for recurrence or death.

Janet Jones' life changed drastically when she went from oncology nurse to patient with breast cancer.

A recent study found that weightlifting and resistance training may be a viable option to mitigate the risk and progression of lymphedema.

A recent study reports that there are mary barriers Latina survivors of breast cancer face.

While the breast cancer mortality rate in many nations has declined, this is not true of South Korea and Latin America.

Debu Tripathy on the management of patients with breast cancer on oral oncolytics.

For patients with breast cancer who have undergone breast reconstruction surgery, radiation therapy could increase complications and lower patient-reported satisfaction.

Sam Smith, PhD, from the University of Leeds, discusses strategies to improve adherence that is affected by menopausal symptoms.

A recent study suggests that if a patient with breast cancer shows no signs of cancer prior to adjuvant chemotherapy and no signs of cancer after a sentinel lymph node biopsy (SLNB), an axillary lymph node biopsy (ALNB) could be avoided.

Jame Abraham on the patient experience during scalp cooling for chemotherapy-induced hair loss.

A nurse relates her experience with breast cancer and the added stress of staph infection from a chemotherapy port.

Julie Nangia, MD, gives advice for patients expecting to lose their hair as a result of chemotherapy.

Scalp cooling to reduce, or prevent, chemotherapy-induced hair loss has not been utilized as frequently in the US as elsewhere around the world.